Skip to main content

Table 3 SF12, FSS and mMRC scores comparison at 6 and 12 months follow up between severe and non-severe respiratory status at inclusion

From: Fatigue and quality-of-life in the year following SARS-Cov2 infection

  Severea Non-severeb p value
6 months (N) 42 78  
 SF12    
  PCS12 (mean ± SD) 42.7 ± 9.7 42.9 ± 10.2 0.87
  MCS12 (mean ± SD) 46.6 ± 7.8 46.7 ± 7.5 0.87
 FSS    
 (Mean ± SD) 29.8 ± 17.0 31.4 ± 16.9 0.64
 mMRC    
 (Median, Q1–Q3) 1, 0–1.8 1, 0–2 0.67
12 months (N) 42 78  
 SF12    
  PCS12 (mean ± SD) 42.2 ± 9.1 42.2 ± 9.8 0.92
  MCS12 (mean ± SD) 48.0 ± 6.4 46.7 ± 6.4 0.16
 FSS    
 (Mean ± SD) 29.5 ± 17.1 34.0 ± 17.9 0.22
 mMRC    
 (Median, Q1–Q3) 1, 0–1 1, 0–2 0.45
  1. aIncludes severe initial pneumonia and acute respiratory distress syndrome (ARDS). Criteria for severe pneumonia were: fever and SpO2 < 90% or respiratory rate > 30/min or acute respiratory failure needing respiratory support (invasive or not) and/or admission in ICU and/or acute circulatory failure (sepsis or septic shock)
  2. bIncludes respiratory symptoms without identified pneumonia